Ontogeny of human fetal plasma progesterone, deoxycorticosterone, and deoxycorticosterone sulfate (cas 1420-82-2)☆
-
Add time:10/01/2019 Source:sciencedirect.com
The concentrations of progesterone, deoxycorticosterone (DOC), and deoxycorticosterone sulfate (DOC-SO4) were determined in mixed umbilical cord plasma of abortuses and newborn infants delivered between 18 and 42 weeks' gestation. A wide range of values among individual samples was found for progesterone (224 to 2,152 ng/ml), DOC (1.6 to 10.4 ng/ml), and DOC-SO4 (17 to 154 ng/ml). Levels of progesterone and DOC in mixed umbilical cord plasma were not correlated; those of DOC and DOC-SO4 were positively correlated significantly (r = 0.3945, P < 0.001). Whereas the mean plasma levels of DOC were similar throughout gestation, significant variation, as a function of gestational age, was found for progesterone and DOC-SO4, with levels of these steroids generally being higher near term than earlier in gestation. The administration of glucocorticosteroids to the mother resulted in a significant decrease (p < 0.001) in plasma concentrations of DOC and DOC-SO4 in the newborn infant; levels of progesterone in umbilical cord plasma were not affected by maternal glucocorticosteroid treatment. These results suggest that the fetal adrenal glands play a direct, or possibly an indirect, role in the production of the DOC and DOC-SO4 that is present in the fetal compartment. In addition, since fetal plasma levels of progesterone are quite high throughout gestation, the potential exists for circulating progesterone to serve as a precursor for adrenal and extra-adrenal production of DOC and DOC-SO4.
We also recommend Trading Suppliers and Manufacturers of deoxycorticosterone sulfate (cas 1420-82-2). Pls Click Website Link as below: cas 1420-82-2 suppliers
Prev:Metabolic clearance rate of plasma deoxycorticosterone sulfate (cas 1420-82-2) in men and women
Next:Paper of the Society for Gynecologic InvestigationConcentrations of deoxycorticosterone, deoxycorticosterone sulfate (cas 1420-82-2), and progesterone in maternal venous serum and umbilical arterial and venous sera☆☆☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Origin of deoxycorticosterone sulfate (cas 1420-82-2) (DOC-SO4) in plasma of pregnant women: Pregnenolone-3,21-disulfate is a placental precursor of DOC-SO409/30/2019
- Origin of deoxycorticosterone and deoxycorticosterone sulfate (cas 1420-82-2) in human pregnancy: Absence of steroid 21-sulfatase activity in sulfatase-deficient placenta09/29/2019
- Paper of the Society for Gynecologic InvestigationConcentrations of deoxycorticosterone, deoxycorticosterone sulfate (cas 1420-82-2), and progesterone in maternal venous serum and umbilical arterial and venous sera☆☆☆09/28/2019
- Metabolic clearance rate of plasma deoxycorticosterone sulfate (cas 1420-82-2) in men and women09/27/2019
- Differential hypothalamic–pituitary–adrenal activation of the neuroactive steroids pregnenolone sulfate and deoxycorticosterone in healthy controls and alcohol-dependent subjects09/26/2019
- Umbilical cord plasma concentrations of deoxycorticosterone sulfate (cas 1420-82-2) in anencephalic fetuses☆09/25/2019
- A radioimmunoassay for deoxycorticosterone sulfate (cas 1420-82-2) without hydrolysis09/24/2019
-
Health and Chemical more >
-
Related Products


